Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial

Overview of attention for article published in Critical Care, April 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 33 news outlets
blogs: 1 blog

twitter: 30 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 62 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 52 X posts from 30 X users, with an upper bound of 282,704 followers.

RT @Crit_Care: #CritCare #OpenAccess EDITOR’S PICK https://t.co/Kh89E7c0Oa #AUXORA + #CORTICOSTEROIDS: A NEW STANDARD OF CARE IN SEVERE #…

Reply Repost Favourite

RT @Crit_Care: #CritCare #OpenAccess EDITOR’S PICK https://t.co/Kh89E7c0Oa #AUXORA + #CORTICOSTEROIDS: A NEW STANDARD OF CARE IN SEVERE #…

Reply Repost Favourite

RT @Crit_Care: #CritCare #OpenAccess EDITOR’S PICK https://t.co/Kh89E7c0Oa #AUXORA + #CORTICOSTEROIDS: A NEW STANDARD OF CARE IN SEVERE #…

Reply Repost Favourite

#CritCare #OpenAccess EDITOR’S PICK https://t.co/Kh89E7c0Oa #AUXORA + #CORTICOSTEROIDS: A NEW STANDARD OF CARE IN SEVERE #COVID_19 #PNEUMONIA? #FOAMed #FOAMcc #BMC #ICU #lung #respiratory_failure #ARDS #cytokine #calcium_channel #immunology #Sars_CoV2 @

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 48 additional X posts.